T/CAQ 29019-2024 Quality Chinese medicinal herbs, Angelica sinensis (Sanchi Ganyao)

Scope

Scope: This document specifies the requirements, testing methods, inspection rules, judgment rules, labeling, packaging, and storage for quality traditional Chinese medicinal materials such as angelica. This document is applicable to the evaluation of quality traditional Chinese medicinal materials such as angelica. Main technical content: Angelica is a traditional and commonly used Chinese medicinal material in China, which has the functions of replenishing blood, promoting blood circulation, regulating menstruation and relieving pain, and moisturizing the intestines and promoting defecation. The "Pharmacopoeia of the People's Republic of China" (2020 Edition) Part I stipulates requirements such as "appearance", "identification", "inspection", "extraction", and "content" for angelica. At the same time, the "General Principles of Pharmacopoeia of the People's Republic of China" (GB/T 2341-2009) stipulates the determination methods for pesticide residues and sets the "basic" standards for angelica. However, the standard's requirements for heavy metal, fungal toxin, and sulfur dioxide content in angelica only need to comply with relevant regulations, which cannot meet the diverse needs of the angelica medicinal material market transactions. Establishing quality standards for angelica medicinal materials has become an inevitable requirement for quality grading management. In order to better evaluate the quality of angelica and meet the needs of graded transactions in the angelica medicinal material market, quality angelica medicinal materials have emerged, which are also an integral part of quality medicinal materials. The quality indicators of quality angelica medicinal materials are higher than those in the "Pharmacopoeia of the People's Republic of China", and the limit requirements for exogenous pollutants and other indicators are lower than those in the "Pharmacopoeia of the People's Republic of China". Compared with the provisions in the "Pharmacopoeia of the P

Development Information

Related Standards